These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 13234288)

  • 1. [Antilipemic and non-anticoagulant decomposition product of heparin].
    ZOLLNER N; ROTHEMUND E; SEITZ W
    Klin Wochenschr; 1954 Dec; 32(45-46):1096-7. PubMed ID: 13234288
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of the antilipemic and anticoagulant activity of a heparin derivative].
    REGAZZINI A; RODARI T
    Rass Fisiopatol Clin Ter; 1961 Apr; 33():301-16. PubMed ID: 14491056
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental studies of the problem of the antilipemic eff. of heparin.
    INDERBITZIN T
    Schweiz Med Wochenschr; 1954 Oct; 84(40):1150-4. PubMed ID: 13225615
    [No Abstract]   [Full Text] [Related]  

  • 4. Antilipemic activities of several new heparinoids.
    HLADOVEC J; ROUBAL Z; MANSFELD V
    Experientia; 1957 May; 13(5):190-1. PubMed ID: 13447921
    [No Abstract]   [Full Text] [Related]  

  • 5. [Oral activity of an antilipemic heparide: N-monomethyl-3,5-dimethylbenzheparide amide].
    PLOTKA C; BUCOURT R; POTTIER J
    C R Hebd Seances Acad Sci; 1963 Jun; 256():5239-41. PubMed ID: 13944082
    [No Abstract]   [Full Text] [Related]  

  • 6. Antilipemic effect of heparin and phenindione.
    CHOUHAN BS; GUPTA NN
    Indian J Med Sci; 1963 Apr; 17():294-9. PubMed ID: 14021036
    [No Abstract]   [Full Text] [Related]  

  • 7. Antilipaemic agent without anticoagulant action.
    BESTERMAN EM; EVANS J
    Br Med J; 1957 Feb; 1(5014):310-2. PubMed ID: 13396242
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anticholesteremic and antilipemic effects of a non-estrogenic hexoestrol derivative known as coronary dilator].
    ANNONI G; LONGARETTI A
    Med Welt; 1961 Sep; 38():1945-7. PubMed ID: 13861698
    [No Abstract]   [Full Text] [Related]  

  • 9. SUBLINGUAL HEPARIN; THE INABILITY TO DETECT LIPID-CLEARING OR ANTICOAGULANT EFFECTS OF HIGH DOSES.
    SPUDIS EV; HUTAFF LW; MILLER HS; LOFLAND H
    Neurology; 1965 May; 15():486-90. PubMed ID: 14288641
    [No Abstract]   [Full Text] [Related]  

  • 10. Selection for anticoagulant therapy in cardiac infarction using the heparin retarded coagulation time.
    PEEL AA
    Br Heart J; 1956 Jul; 18(3):378-84. PubMed ID: 13342301
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antilipemic and hyperglycemic heparin effects in alloxan diabetes].
    LUSZTIG G; HORVATH E; KOSZEGI B; ORMOS J
    Z Gesamte Inn Med; 1955 Jun; 10(11):548-52. PubMed ID: 13257348
    [No Abstract]   [Full Text] [Related]  

  • 12. [On a biological test for antilipemic derivatives of heparin].
    HERBAIN M
    Clin Chim Acta; 1960 Mar; 5():204-7. PubMed ID: 14401197
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antilipemic effect of heparin. II. Changes of lipid concentration and lipase activity; problems of the reversibility of heparin action].
    GERO S; ROHNY B; GACS J
    Magy Belorv Arch (1955); 1958 Feb; 11(1):29-33. PubMed ID: 13551235
    [No Abstract]   [Full Text] [Related]  

  • 14. [Problems of blood coagulation. V. Effect of heparin-like anticoagulants on the first phase of blood coagulation].
    MARBET R; WINTERSTEIN A
    Helv Physiol Pharmacol Acta; 1952; 10(4):528-42. PubMed ID: 13044146
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antilipemic and fibrinolytic activity of an extractive mucopolysaccharide in atherosclerotic disease].
    Isidori A; Butti A; Rossi G
    Minerva Med; 1969 Dec; 60(99 Suppl):5077-81. PubMed ID: 4188592
    [No Abstract]   [Full Text] [Related]  

  • 16. [ANTILIPEMIC EFFECT OF ACID SODIUM HEPARIN AFTER SUBLINGUAL OR RECTAL ADMINISTRATION].
    SCHOELL H; KOPITZKI F
    Klin Wochenschr; 1964 Jul; 42():699-707. PubMed ID: 14250912
    [No Abstract]   [Full Text] [Related]  

  • 17. [METHODS OF EVALUATING ANTILIPEMIC ACTION IN VIVO AND IN VITRO IN RATS].
    HORNACEK J; HLADOVEC J; KRPATOVA J
    Cas Lek Cesk; 1963 May; 102():641-4. PubMed ID: 14077274
    [No Abstract]   [Full Text] [Related]  

  • 18. [Influence of nonachlazin, riboxin and isoptin on the blood coagulation system and the anticoagulant effect of heparin].
    Shevchenko LV; Ovchinnikova LK; Zolotukhin SI
    Farmakol Toksikol; 1980; 43(4):389-95. PubMed ID: 7439373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulant and antilipemic activities of a heparin proteoglycan from bovine intestinal mucosa.
    Seethanathan P; Ehrlich K
    Thromb Res; 1980 Jul 1-15; 19(1-2):95-102. PubMed ID: 7444861
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the antilipemic effect of a superior homologue of nicotinic acid, 3-pyridylacetic acid].
    MEARDI G; GRANDINI U; AIRO R; POGGI C
    Minerva Med; 1961 Dec; 52():4200-4. PubMed ID: 14471930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.